New SEC Form D filing
Axelyf, Inc., 2026-10-13
A new SEC Form D private-offering notice from Chestnut Hill, MA, a $2,700,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
RNA therapeutics biotech developing lipid nanoparticle delivery technology for oncology and autoimmune disease treatments
Filed 2026-10-13Filed to raise $2,700,000First money in 2026-10-07Raised so far $2,631,439HQ (as filed) Chestnut Hill, MASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified axelyf.com↗Named in the filing 3 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- OpsMate AI, Inc., 2026-10-15, $3.4M, Westwood, MA
- EpiVario Inc., 2026-10-13, $500K, Philadelphia, PA
- AeroShield Materials, Inc., 2026-10-15, $15M, Waltham, MA
- Thetis Pharmaceuticals LLC, 2026-10-13, $1M, Deep River, CT
- Soterya, Inc., 2026-10-13, $2M, Boston, MA
- FibroBiologics, Inc., 2026-10-13, $1.2M, Houston, TX
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.